Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Elekta AB is a Swedish company specializing in the development and production of medical technologies used in radiotherapy and radiosurgery for treating cancer and brain disorders. Founded in 1972 and headquartered in Stockholm, Sweden, Elekta offers a range of products including linear accelerators, brachytherapy solutions, and software for treatment planning and digital health records management. The company is recognized for its emphasis on precision and efficiency in treatment delivery. Elekta operates globally, serving hospitals and cancer care centers across multiple continents, leveraging technological innovations to improve patient outcomes and workflow efficiency in healthcare facilities. Its strategic focus includes the continuous advancement of image-guided radiation therapy technologies.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Elekta ABEli Lilly
Last price
kr 59.45$1,417.54
Currency
SEK
USD
kr 23B$1.2T
-44.58
-kr 0.95$30.81
0.97-
kr 2.40$6.69
4.09%0.50%
Sector
HealthHealth
Employees
3,99650,000
Ticker
Skr EKTA B$LLY
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrEKTA B or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.